The telehealth company Hims & Hers is adding Zepbound and generic liraglutide to its offering of weight-loss drugs.

Zepbound is available in both prefilled pens and vials, with the pens offering a wider range of doses and the vials requiring syringe administration. If deemed appropriate, your healthcare ...

Medications targeting weight loss like Wegovy and Zepbound are part of a relatively new class of drugs that work by suppressing appetite and food intake. They’ve been hailed as not only life-changing ...

A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability issue of obesity medications such as Wegovy and Zepbound.

A Lilly spokesperson said in a statement that the company has "no affiliation" with Hims & Hers and noted that Zepbound is ...

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

Medicare coverage for anti-obesity drugs was not finalized, affecting drugs like Wegovy and Zepbound. Covering weight loss drugs may cost $35 billion from 2026–2034, with estimated savings under ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

In a statement on its website, Eli Lilly and Company (LLY) said it has no affiliation with hims & hers (HIMS). It added, “Zepbound can be ...

The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.

The company said Tuesday it now provides access to Zepbound, a brand-name version of the drug tirzepatide, as well as to generic liraglutide. Zepbound is made by drugmaker Eli Lilly. While Hims ...